Edward T. Van Matre, PharmD, MS, BCCCP

Assistant Professor
Department of Clinical Pharmacy & Translational Science and Pharmacology
University of Tennessee College of Pharmacy

Office: 339 COLLEGE OF PHARMACY BUILDING
881 MADISON AVENUE
MEMPHIS TN 381632198
Tel: (901) 448-2989
edward.vanmatre@uthsc.edu

Education

  • None, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora CO, Critical Care Research Fellowship
  • M.S., University of Colorado Anschutz Medical Campus, Aurora CO, Clinical Science
  • None, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora CO, PGY2 Critical Care Residency
  • None, University of Kentucky, Lexington KY, PGY1 Residency
  • Pharm.D., University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora CO, Doctor of Pharmacy
  • B.S., Oklahoma State University, Stillwater OK, Biochemistry and Molecular Biology

Research Interest/Specialty

Cliniacl pharmacokinetics and Pharmacodynamics in Critically Ill Patietns 

Clinical Care Specialty/Interest

Clinical Practice site is the Nutrition Support Services and Trauma ICU at Regional One Health.

Publications

  1. Smetana, KS, Ziemba, R, May, CC, Erdman, MJ, Van Matre, ET, Jones, GM. Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding. J Thromb Thrombolysis, 2018.
  2. Van Matre, ET, Reynolds, PM, MacLaren, R, Mueller, SW, Wright, GC, Moss, M, Burnham, EL, Ho, PM, Vandivier, RW, Kiser, TH. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. J Thromb Haemost, 2018.
  3. Kassel, LE, Van Matre, ET, Foster, CJ, Fish, DN, Mueller, SW, Sherman, DS, Wempe, MF, MacLaren, R, Neumann, RT, Kiser, TH. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients. Pharmacotherapy, 38 (9), 921-934, 2018.
  4. Van Matre ET, Satyanarayana G, Page 2nd RL, Levi ME, Lindenfeld J, Mueller SW. Pharmacokinetic Drug-Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids.. Ann Transplant, 23, 66-74, 2018.
  5. Van Matre, ET, Ho, KC, Lyda, C, Fullmer, BA, Oldland, AR, Kiser, TH. Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags. Hosp Pharm, 52 (8), 570-573, 2017.
  6. Van Matre, ET, Mueller, SW, Fish, DN, MacLaren, R, Cava, LF, Neumann, RT, Kiser, TH. Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration. Am J Case Rep, 18, 458-462, 2017.
  7. Trinkley, KE, Van Matre, ET, Mueller, SW, Page, RL, Nair, K. Perceived Benefit of Teaching Patient Safety to Pharmacy Students by Integrating Classroom Teaching With Introductory (IPPE) Visits. J Pharm Pract, 30 (1), 115-120, 2017.
  8. Van Matre, ET, Cook, AM. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients. Neurol Res, 38 (9), 786-91, 2016.
  9. Van Matre, ET, Sherman, DS, Kiser, TH. Management of intracerebral hemorrhage--use of statins. Vasc Health Risk Manag, 12, 153-61, 2016.